BPC-157: Infrastructure for Healing BPC-157's core mechanism centers on angiogenesis the formation of new blood vessels
Similar findings were observed in the SURMOUNT-5 trial, presented at the European Congress on Obesity and simultaneously published in The New England Journal of Medicine , as adults with obesity or overweight plus one obesity-related comorbidity achieved greater weight loss at 72 weeks with tirzepatide vs
Another set of junction proteins, the adherens, are involved in the development, stabilization and organization of the intercellular junctions at the endothelium, and involve cadherins, catenins, PECAM-1, and the junctional adhesion molecules (JAMs) -A, -B, -C and endothelial cell-selective adhesion molecule (ESAM) [12, 13]
This is due to something called bioavailability
I think they are promising but Im not sold just yet for me personally because of the lack of data and regulation